MBX.to $1.38, has been making highs lately...supposedly they will announce who their international partner later this month....they have the technology to grow viruses quickly and in great numbers...needed for manufacture of innoculations, etc., which are in short supply each flu season....I have owned this for over 5 years...still do.
Recently signed a deal with GE....this is an old PR.
TORONTO, July 26 /CNW/ - Microbix Biosystems, Inc. (TSX: MBX - News) today announced it has signed a contract with GE Healthcare (a combination of the former Amersham and GE Medical Systems) aimed at facilitating faster and more efficient drug development.
Under the terms of the contract, Microbix will develop a portfolio of recombinant adenoviruses for use with GE Healthcare's sub-cellular imaging systems, the IN Cell Analyzer 3000 and IN Cell Analyzer 1000. A range of ready-to-use assays will be developed to enable researchers to study key cellular events in real-time and in a cell line of choice. This will enable more biologically relevant results to be obtained, and so advance the drug discovery process.
"This contract is the latest in the continuing successful commercialization of our core technology platforms, and confirms that we remain market leader in the area of adenovirus technologies," said William J. Gastle, President and CEO.
About Microbix
Microbix specializes in developing proprietary biological technologies. The Company has a core technology platform based on cell biology, purification and characterization of viruses and proteins. Microbix' objective is to develop and, through global marketing partners, commercialize those technologies that can be brought to market in less than five years.
About GE Healthcare
GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. GE Healthcare's expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceuticals is dedicated to detecting disease earlier and tailoring treatment for individual patients. GE Healthcare offers a broad range of services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, Alzheimer's and cardiovascular diseases.
GE Healthcare is a $14 billion unit of General Electric Company (NYSE: GE - News) that is headquartered in the United Kingdom. Worldwide, GE Healthcare employs more than 42,500 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit their website at www.gehealthcare.com
This press release contains forward-looking statements, which are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company disclaims any intent or obligation to update these forward-looking statements. |
